The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Jan. 23, 2018
Applicant:

Institut Gustave-roussy, Villejuif, FR;

Inventors:

Jean Luc Perfettini, Meaux, FR;

Eric Deutsch, Paris, FR;

Catherine Brenner, Le Chesnay, FR;

Jean-Christophe Cintrat, Igny, FR;

Frederic Taran, Gif sur Yvette, FR;

Assignee:

Institut Gustave Roussy, Villejuif, FR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/15 (2006.01); A61K 31/513 (2006.01); A61N 5/10 (2006.01); A61P 35/00 (2006.01); A61K 31/5377 (2006.01); A61K 31/4166 (2006.01); G01N 33/50 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/0019 (2013.01); A61K 31/15 (2013.01); A61K 31/4166 (2013.01); A61K 31/513 (2013.01); A61N 5/10 (2013.01); A61P 35/00 (2018.01); G01N 33/5011 (2013.01); A61N 2005/1098 (2013.01); G01N 2510/00 (2013.01);
Abstract

The present invention is drawn to the use of the compounds highlighted in Tables 1 & 2 and analogs thereof, for enhancing IR-mediated cellular cannibalism in cancer cells. Said compounds are herein called 'enhancers of IR-mediated cellular cannibalism'. They can be used to enhance tumor immunogenicity and/or to induce a significant protective anticancer immune response in subjects that will receive or that have received a radiotherapy treatment. In other words, said compounds can be used to potentiate a radiotherapy treatment in a subject in need thereof. Said compounds are preferably chosen in the group consisting of: Mebhydroline 1,5-napthalene disulfonate salt, Flurbiprofen, Minaprine dihydrochloride, Myricetin, Digoxin, Digitoxin, Lanatoside, LOPA87, VP331, RN-1-026, SG6163F, VP450, and VP43.


Find Patent Forward Citations

Loading…